FDA hearings focus on need for guidelines
WASHINGTON: The pharmaceutical industry and healthcare communicators advocated for guidelines that would define the way they use the Web to communicate during the Food and Drug Administration (FDA)'s two-day social media hearings.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>